Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Loyola University Medical Center
mi
from
Chicago, IL
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Loyola University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Delnor Community Hospital
mi
from
Geneva, IL
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Delnor Community Hospital
mi
from
Geneva, IL
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Ingalls Memorial Hospital
mi
from
Harvey, IL
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Ingalls Memorial Hospital
mi
from
Harvey, IL
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Orchard Healthcare Research
mi
from
Northbrook, IL
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Orchard Healthcare Research
mi
from
Northbrook, IL
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
CDH Cancer Center
mi
from
Winfield, IL
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
CDH Cancer Center
mi
from
Winfield, IL
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
IU Health Bloomington
mi
from
Bloomington, IN
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
IU Health Bloomington
mi
from
Bloomington, IN
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Covenant Medical Center
mi
from
Waterloo, IA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Covenant Medical Center
mi
from
Waterloo, IA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
MedStar Harbor Hospital
mi
from
Baltimore, MD
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
MedStar Harbor Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Harry and Jeanette Weinberg Cancer Institute at Franklin Square
mi
from
Baltimore, MD
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Harry and Jeanette Weinberg Cancer Institute at Franklin Square
mi
from
Baltimore, MD
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Mercy Medical Center
mi
from
Baltimore, MD
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Mercy Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Western Maryland Health System, Inc.
mi
from
Cumberland, MD
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Western Maryland Health System, Inc.
mi
from
Cumberland, MD
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Lahey Clinic
mi
from
Burlington, MA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Mount Auburn Hospital
mi
from
Cambridge, MA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Mount Auburn Hospital
mi
from
Cambridge, MA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
MetroWest Medical Center
mi
from
Framingham, MA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
MetroWest Medical Center
mi
from
Framingham, MA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Detroit Clinical Research Center
mi
from
Detroit, MI
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Detroit Clinical Research Center
mi
from
Detroit, MI
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Virginia Piper Cancer Institute
mi
from
Minneapolis, MN
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Virginia Piper Cancer Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
St. Louis Cancer Care
mi
from
Bridgeton, MO
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
St. Louis Cancer Care
mi
from
Bridgeton, MO
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
SSM Cancer Center
mi
from
St. Louis, MO
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
SSM Cancer Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Roswell Park Cancer Center
mi
from
Buffalo, NY
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Roswell Park Cancer Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
North Shore/Monter Cancer Center
mi
from
Lake Success, NY
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
North Shore/Monter Cancer Center
mi
from
Lake Success, NY
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Columbia University
mi
from
New York, NY
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
University of Oklahoma
mi
from
Oklahoma City, OK
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Tulsa Cancer Institute, Pllc
mi
from
Tulsa, OK
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Tulsa Cancer Institute, Pllc
mi
from
Tulsa, OK
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
St. Mary Medical Center
mi
from
Langhorne, PA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
St. Mary Medical Center
mi
from
Langhorne, PA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
St. Clair Hospital
mi
from
Pittsburgh, PA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
St. Clair Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Charleston Cancer Center
mi
from
Charleston, SC
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Charleston Cancer Center
mi
from
Charleston, SC
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Cookeville Regional Medical Center
mi
from
Cookeville, TN
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Cookeville Regional Medical Center
mi
from
Cookeville, TN
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Knoxville Comprehensive Breast Center
mi
from
Knoxville, TN
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Knoxville Comprehensive Breast Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Nashville Breast Center
mi
from
Nashville, TN
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Nashville Breast Center
mi
from
Nashville, TN
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Texas Health
mi
from
Dallas, TX
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Texas Health
mi
from
Dallas, TX
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Hematology/Oncology Associates
mi
from
Alexandria, VA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Hematology/Oncology Associates
mi
from
Alexandria, VA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Lynchburg Hematology-Oncology Clinic
mi
from
Lynchburg, VA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Lynchburg Hematology-Oncology Clinic
mi
from
Lynchburg, VA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Swedish Cancer Institute
mi
from
Seattle, WA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Columbia St. Mary's Cancer Center
mi
from
Milwaukee, WI
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Columbia St. Mary's Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Aurora Advanced Healthcare
mi
from
Milwaukee, WI
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Aurora Advanced Healthcare
mi
from
Milwaukee, WI
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
Wheaton Franciscan Cancer Care - All Saints
mi
from
Racine, WI
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
Wheaton Franciscan Cancer Care - All Saints
mi
from
Racine, WI
Click here to add this to my saved trials
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated:  1/28/2016
St. Vincent Hospital
mi
from
Worcester, MA
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Status: Enrolling
Updated: 1/28/2016
St. Vincent Hospital
mi
from
Worcester, MA
Click here to add this to my saved trials
Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy
A Pilot Study of Intraoperative Margin Assessment Comparing Optical Spectroscopy and Frozen Section Analysis for Ductal Carcinoma In Situ of the Breast
Status: Enrolling
Updated:  1/28/2016
University of Wisconsin
mi
from
Madison, WI
Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy
A Pilot Study of Intraoperative Margin Assessment Comparing Optical Spectroscopy and Frozen Section Analysis for Ductal Carcinoma In Situ of the Breast
Status: Enrolling
Updated: 1/28/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Sedona, AZ
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Sedona, AZ
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Highland, CA
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Highland, CA
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Sacramento, CA
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
San Diego, CA
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
San Francisco, CA
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Santa Rosa, CA
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Vallejo, CA
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Vallejo, CA
Click here to add this to my saved trials
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
mi
from
Newark, DE
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
mi
from
Newark, DE
Click here to add this to my saved trials